<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Flow cytometry has also been used to study the nuclear DNA content (ploidy) and cell cycle kinetics of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Studies of limited numbers of patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> undergoing endoscopic surveillance suggested that <z:mp ids='MP_0004024'>aneuploidy</z:mp> may be a useful marker to identify subsets of patients at increased risk for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Few studies to date have evaluated premalignant tissues associated with the development of <z:e sem="disease" ids="C0007137,C0751688" disease_type="Neoplastic Process" abbrv="">squamous-cell cancer</z:e> of the esophagus </plain></SENT>
<SENT sid="3" pm="."><plain>The present retrospective study comprises 80 surgical specimens of <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo> of the esophagus from a high-incidence region of Thailand </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had surgery at the Department of Surgery, Prince of Songkla University, between March 1983 and December 1993 </plain></SENT>
<SENT sid="5" pm="."><plain>Sets of serial sections were cut every 0.5 cm starting from the proximal margin and down to the distal margin, and histopathology was confirmed to flow cytometric parameters (DNA content, S-phase fraction) </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0004024'>Aneuploidy</z:mp> was found in 84% of <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo>, 22.2% of <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ, 28.6% of severe <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 11.0% of moderate <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 0% of mild <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal mucosa specimens </plain></SENT>
<SENT sid="7" pm="."><plain>The percentage was higher according to the level of severity or <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>S-phase fraction was found to be 21.0 +/- 0.9% in <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo>, 20.3 +/- 10.3% of <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ, 20.9 +/- 5.3% of severe <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 12.9 +/- 9.7% of moderate <z:mpath ids='MPATH_589'>dysplasia</z:mpath> 7.6 +/- 0.8% of mild <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 8.9 +/- 3.2% of <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="9" pm="."><plain>Similarly, the percentage of S-phase fraction tends to be higher according to the level of severity or <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>These findings demonstrate that the <z:mp ids='MP_0004024'>aneuploidy</z:mp> and percentage of S-phase fraction tend to correlate with progression of esophageal premalignant tissues to invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>These measures may be clinically useful to identify patients at increased risk for esophageal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>